Timothy F. Fidgeon’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$3.12M Buy
114,920
+1,490
+1% +$42.2K 1.54% 21
2015
Q2
$3.11M Buy
113,430
+12,610
+13% +$354K 1.38% 24
2015
Q1
$2.69M Buy
100,820
+740
+0.7% +$17K 1.16% 29
2014
Q4
$2.12M Buy
100,080
+2,450
+3% +$54.7K 0.96% 32
2014
Q3
$2.33M Buy
97,630
+320
+0.3% +$7.36K 1.09% 33
2014
Q2
$2.25M Buy
97,310
+6,170
+7% +$136K 1.03% 35
2014
Q1
$2.08M Sell
91,140
-260
-0.3% -$5.54K 0.99% 38
2013
Q4
$1.69M Sell
91,400
-2,850
-3% -$49.7K 0.8% 40
2013
Q3
$1.6M Hold
94,250
0.82% 41
2013
Q2
$1.46M Buy
+94,250
New +$1.57M 0.79% 42

Other funds holding NVO

Timothy F. Fidgeon's NVO Position: Q3 2015 in Review

Timothy F. Fidgeon increased its Novo Nordisk (NVO) stake by 1.3% in Q3 2015, buying an estimated $42.2K and bringing the position to 114,920 shares worth $3.12M. The position accounts for 1.54% of the portfolio, ranked #21.

Timothy F. Fidgeon first reported a position in NVO in Q2 2013 and has held it in 10 quarters since. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

  • Timothy F. Fidgeon held 114,920 shares of Novo Nordisk worth $3.12M as of Q3 2015.
  • Timothy F. Fidgeon bought 1,490 Novo Nordisk shares in Q3 2015, an estimated $42.2K.
  • Novo Nordisk made up 1.54% of Timothy F. Fidgeon's portfolio in Q3 2015, its #21 holding.
  • Timothy F. Fidgeon first reported a position in Novo Nordisk in Q2 2013 and has held it in 10 quarters since.
  • 525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on Timothy F. Fidgeon's 13F filing for Q3 2015, filed 13 Nov 2015.